Yang JL - Search Results

1

Regulatory roles and therapeutic potential of microRNA in sarcoma.

Lim HJ, Yang JL. Lim HJ, et al. Among authors: yang jl. Crit Rev Oncol Hematol. 2016 Jan;97:118-30. doi: 10.1016/j.critrevonc.2015.08.001. Epub 2015 Aug 10. Crit Rev Oncol Hematol. 2016. PMID: 26318097 Review.

2

Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines.

Lim HJ, Wang X, Crowe P, Goldstein D, Yang JL. Lim HJ, et al. Among authors: yang jl. Anticancer Res. 2016 Nov;36(11):5765-5771. doi: 10.21873/anticanres.11160. Anticancer Res. 2016. PMID: 27793898

3

Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.

Lim HJ, Crowe P, Yang JL. Lim HJ, et al. Among authors: yang jl. J Cancer Res Clin Oncol. 2015 Apr;141(4):671-89. doi: 10.1007/s00432-014-1803-3. Epub 2014 Aug 22. J Cancer Res Clin Oncol. 2015. PMID: 25146530 Review.

4

Nanoparticle-siRNA: A potential cancer therapy?

Young SW, Stenzel M, Yang JL. Young SW, et al. Among authors: yang jl. Crit Rev Oncol Hematol. 2016 Feb;98:159-69. doi: 10.1016/j.critrevonc.2015.10.015. Epub 2015 Oct 31. Crit Rev Oncol Hematol. 2016. PMID: 26597018 Review.

5

microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review).

Wong MY, Yu Y, Walsh WR, Yang JL. Wong MY, et al. Among authors: yang jl. Int J Oncol. 2011 May;38(5):1189-95. doi: 10.3892/ijo.2011.970. Epub 2011 Mar 10. Int J Oncol. 2011. PMID: 21399872 Review.

6

Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines.

Wang X, Goldstein D, Crowe PJ, Yang JL. Wang X, et al. Among authors: yang jl. Int J Oncol. 2018 Jun;52(6):2143-2154. doi: 10.3892/ijo.2018.4337. Epub 2018 Mar 27. Int J Oncol. 2018. PMID: 29620166

7

STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review).

Wang X, Crowe PJ, Goldstein D, Yang JL. Wang X, et al. Among authors: yang jl. Int J Oncol. 2012 Oct;41(4):1181-91. doi: 10.3892/ijo.2012.1568. Epub 2012 Jul 24. Int J Oncol. 2012. PMID: 22842992 Review.

8

The Potential of panHER Inhibition in Cancer.

Wang X, Batty KM, Crowe PJ, Goldstein D, Yang JL. Wang X, et al. Among authors: yang jl. Front Oncol. 2015 Jan 28;5:2. doi: 10.3389/fonc.2015.00002. eCollection 2015. Front Oncol. 2015. PMID: 25674538 Free PMC article. Review.

9

Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma.

Wang X, Goldstein D, Crowe PJ, Yang M, Garrett K, Zeps N, Yang JL. Wang X, et al. Among authors: yang jl, yang m. Oncotarget. 2016 Apr 19;7(16):21496-509. doi: 10.18632/oncotarget.7452. Oncotarget. 2016. PMID: 26909593 Free PMC article.

10

Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma.

Yang JL, Gupta RD, Goldstein D, Crowe PJ. Yang JL, et al. Int J Mol Sci. 2017 May 30;18(6):1159. doi: 10.3390/ijms18061159. Int J Mol Sci. 2017. PMID: 28556791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,346 results

Search Page